Free teaser · full plain English is Pro — see pricing

stockTradersNeutralNear termBenzingaMRNA 

Pharma Bro Admits 'Playing Around' With MRNA Short At $80 Before it Exploded 177% Following Cancer Vax Trials— ‘I Bet You a Bunch of People Got Fired’

Moderna’s cancer‑vaccine win triggered a 177% stock jump that caught many traders off‑balance, exposing gaps in biotech positioning.

ClearTape summarizes context in-app. For the full publisher article, use Read original source above.